Additionally, studies investigating the role of chemerin signaling in IBD pathogenesis have demonstrated that local chemerin expression, secretion, and activation increase in the colon and are positively associated with severity of inflammation (Dranse et al., 2015; Lin et al., 2014; Weigert et al., 2010). Here, RARRES2 is linked to inflammatory bowel disease.